Advertisement

Current Sexual Health Reports

, Volume 10, Issue 3, pp 177–185 | Cite as

Testosterone Therapy: a Panacea for Sexual Dysfunction in Men?

  • Sevann Helo
  • Peyton Thomas
  • Nicholas N. Tadros
Male Sexual Dysfunction and Disorders (AW Pastuszak and NK Gupta, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Male Sexual Dysfunction and Disorders

Abstract

Purpose of Review

In this article, we review the most recent articles examining the use of testosterone for the treatment of erectile dysfunction, reduced sexual desire, and ejaculatory dysfunction.

Recent Findings

The treatment of erectile dysfunction with testosterone therapy has long been investigated as a cure for sexual dysfunction. Men who are testosterone deficient can expect to benefit from testosterone therapy to address erectile dysfunction and libido, while ejaculatory function is unlikely to improve.

Summary

The literature supports the use of testosterone therapy in testosterone-deficient men with sexual dysfunction. We recommend advising patients about the benefits of testosterone therapy while ensuring that it will address their individual concerns, without delaying adjunct treatments for sexual dysfunction.

Keywords

Testosterone Erectile dysfunction Hypogonadism Libido Sexual dysfunction 

Abbreviations

AMS

Aging male symptom

BMSFI

Brief Male Sexual Function Index

ED

Erectile dysfunction

IIEF

International Index of Erectile Function

MSHQ-EjD

Men’s Sexual Health Questionnaire Ejaculatory Dysfunction

NO

Nitric oxide

PDE5

Phosphodiesterase type 5

TD

Testosterone deficiency

TTh

Testosterone therapy

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Zarotsky V, Huang MY, Carman W, Morgentaler A, Singhal PK, Coffin D, et al. Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men. Andrology. 2014;2(6):819–34.  https://doi.org/10.1111/andr.274.CrossRefPubMedGoogle Scholar
  2. 2.
    Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762–9.  https://doi.org/10.1111/j.1742-1241.2006.00992.x. CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Baltimore Longitudinal Study of A. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86(2):724–31.  https://doi.org/10.1210/jcem.86.2.7219. CrossRefPubMedGoogle Scholar
  4. 4.
    •• Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2004;89(12):5920–6.  https://doi.org/10.1210/jc.2003-031719. This was the first large-scale observational study to establish the relationship between testosterone deficiency and aging. CrossRefPubMedGoogle Scholar
  5. 5.
    Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92(11):4241–7.  https://doi.org/10.1210/jc.2007-1245.CrossRefPubMedGoogle Scholar
  6. 6.
    Moskovic DJ, Araujo AB, Lipshultz LI, Khera M. The 20-year public health impact and direct cost of testosterone deficiency in U.S. men. J Sex Med. 2013;10(2):562–9.  https://doi.org/10.1111/j.1743-6109.2012.02944.x.CrossRefPubMedGoogle Scholar
  7. 7.
    Traish AM, Miner MM, Morgentaler A, Zitzmann M. Testosterone deficiency. Am J Med. 2011;124(7):578–87.  https://doi.org/10.1016/j.amjmed.2010.12.027.CrossRefPubMedGoogle Scholar
  8. 8.
    •• Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018:jc.2018-00229-jc.2018-. doi: https://doi.org/10.1210/jc.2018-00229. This publication includes the most recent Endocrine Society guidelines for testosterone therapy.
  9. 9.
    Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54–61.CrossRefPubMedGoogle Scholar
  10. 10.
    Isidori AM, Buvat J, Corona G, Goldstein I, Jannini EA, Lenzi A, et al. A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. Eur Urol. 2014;65(1):99–112.  https://doi.org/10.1016/j.eururo.2013.08.048.CrossRefPubMedGoogle Scholar
  11. 11.
    Mulligan T, Schmitt B. Testosterone for erectile failure. J Gen Intern Med. 1993;8(9):517–21.CrossRefPubMedGoogle Scholar
  12. 12.
    Granata AR, Rochira V, Lerchl A, Marrama P, Carani C. Relationship between sleep-related erections and testosterone levels in men. J Androl. 1997;18(5):522–7.PubMedGoogle Scholar
  13. 13.
    Shabsigh R, Rajfer J, Aversa A, Traish AM, Yassin A, Kalinchenko SY, et al. The evolving role of testosterone in the treatment of erectile dysfunction. Int J Clin Pract. 2006;60(9):1087–92.  https://doi.org/10.1111/j.1742-1241.2006.01101.x.CrossRefPubMedGoogle Scholar
  14. 14.
    Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab. 2006;91(11):4335–43.  https://doi.org/10.1210/jc.2006-0401.CrossRefPubMedGoogle Scholar
  15. 15.
    • Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123–35.  https://doi.org/10.1056/NEJMoa0911101. This is the largest cohort study evaluating symptoms most predictive of testosterone deficiency. CrossRefPubMedGoogle Scholar
  16. 16.
    Karazindiyanoglu S, Cayan S. The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male : Off J Int Soc Stud Aging Male. 2008;11(3):146–9.  https://doi.org/10.1080/13685530802290438. CrossRefGoogle Scholar
  17. 17.
    Okada K, Yamaguchi K, Chiba K, Miyake H, Fujisawa M. Comprehensive evaluation of androgen replacement therapy in aging Japanese men with late-onset hypogonadism. Aging Male: Off J Int Soc Stud Aging Male. 2014;17(2):72–5.  https://doi.org/10.3109/13685538.2014.888052. CrossRefGoogle Scholar
  18. 18.
    McMahon CG, Shusterman N, Cohen B. Pharmacokinetics, clinical efficacy, safety profile, and patient-reported outcomes in patients receiving subcutaneous testosterone pellets 900 mg for treatment of symptoms associated with androgen deficiency. J Sex Med. 2017;14(7):883–90.  https://doi.org/10.1016/j.jsxm.2017.04.734.CrossRefPubMedGoogle Scholar
  19. 19.
    Almehmadi Y, Yassin AA, Nettleship JE, Saad F. Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism. Arab J Urol. 2016;14(1):31–6.  https://doi.org/10.1016/j.aju.2015.10.002.CrossRefPubMedGoogle Scholar
  20. 20.
    Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). J Sex Med. 2011;8(11):3204–13.  https://doi.org/10.1111/j.1743-6109.2011.02436.x.CrossRefPubMedGoogle Scholar
  21. 21.
    Haider KS, Haider A, Doros G, Traish A. Long-term testosterone therapy improves urinary and sexual function, and quality of life in men with hypogonadism: results from a propensity matched subgroup of a controlled registry study. J Urol. 2018;199(1):257–65.  https://doi.org/10.1016/j.juro.2017.07.039.CrossRefPubMedGoogle Scholar
  22. 22.
    Permpongkosol S, Khupulsup K, Leelaphiwat S, Pavavattananusorn S, Thongpradit S, Petchthong T. Effects of 8-year treatment of long-acting testosterone undecanoate on metabolic parameters, urinary symptoms, bone mineral density, and sexual function in men with late-onset hypogonadism. J Sex Med. 2016;13(8):1199–211.  https://doi.org/10.1016/j.jsxm.2016.06.003.CrossRefPubMedGoogle Scholar
  23. 23.
    •• Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611–24.  https://doi.org/10.1056/NEJMoa1506119. This is the largest long-term randomized placebo-controlled clinical trial that has been published evaluating the effect of testosterone therapy on sexual, physical and psychosocial outcomes.
  24. 24.
    Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Bhasin S, Matsumoto AM, et al. Testosterone treatment and sexual function in older men with low testosterone levels. J Clin Endocrinol Metab. 2016;101(8):3096–104.  https://doi.org/10.1210/jc.2016-1645.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    • Rosen RC, Wu F, Behre HM, Porst H, Meuleman EJH, Maggi M et al. Quality of life and sexual function benefits of long-term testosterone treatment: longitudinal results from the Registry of Hypogonadism in Men (RHYME). The journal of sexual medicine. 2017;14(9):1104–15. doi: https://doi.org/10.1016/j.jsxm.2017.07.004. This is the largest and most recent observational study investigating the effect of testosterone therapy on erectile function.
  26. 26.
    • Corona G, Rastrelli G, Morgentaler A, Sforza A, Mannucci E, Maggi M. Meta-analysis of results of testosterone therapy on sexual function based on International Index of Erectile Function Scores. Eur Urol. 2017;72(6):1000–11.  https://doi.org/10.1016/j.eururo.2017.03.032. This is the most recent meta-analysis of the effects of testosterone therapy on erectile function. CrossRefPubMedGoogle Scholar
  27. 27.
    •• Elliott J, Kelly SE, Millar AC, Peterson J, Chen L, Johnston A, et al. Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis. BMJ Open. 2017;7(11):e015284.  https://doi.org/10.1136/bmjopen-2016-015284. This is the most comprehensive meta-analysis evaluating the effect of testosterone therapy on various clinical outcomes and adverse events. PubMedPubMedCentralGoogle Scholar
  28. 28.
    Lugg J, Ng C, Rajfer J, Gonzalez-Cadavid N. Cavernosal nerve stimulation in the rat reverses castration-induced decrease in penile NOS activity. Am J Phys. 1996;271(2 Pt 1):E354–61.  https://doi.org/10.1152/ajpendo.1996.271.2.E354.Google Scholar
  29. 29.
    Giuliano F, Rampin O, Schirar A, Jardin A, Rousseau JP. Autonomic control of penile erection: modulation by testosterone in the rat. J Neuroendocrinol. 1993;5(6):677–83.CrossRefPubMedGoogle Scholar
  30. 30.
    Aversa A, Isidori AM, Greco EA, Giannetta E, Gianfrilli D, Spera E, et al. Hormonal supplementation and erectile dysfunction. Eur Urol. 2004;45(5):535–8.  https://doi.org/10.1016/j.eururo.2004.01.005.CrossRefPubMedGoogle Scholar
  31. 31.
    • Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol. 2004;172(2):658–63.  https://doi.org/10.1097/01.ju.0000132389.97804.d7. This is the first randomized clinical trial showing testosterone therapy improves response to PDE5 inhibitors in men with erectile dysfunction. CrossRefPubMedGoogle Scholar
  32. 32.
    Alexander GM, Sherwin BB. The association between testosterone, sexual arousal, and selective attention for erotic stimuli in men. Horm Behav. 1991;25(3):367–81.  https://doi.org/10.1016/0018-506X(91)90008-6.CrossRefPubMedGoogle Scholar
  33. 33.
    Alexander GM, Swerdloff RS, Wang C, Davidson T, McDonald V, Steiner B, et al. Androgen–behavior correlations in hypogonadal men and eugonadal men. Horm Behav. 1997;31(2):110–9.  https://doi.org/10.1006/hbeh.1997.1372.CrossRefPubMedGoogle Scholar
  34. 34.
    Arver S, Dobs AS, Meikle AW, Allen RP, Sanders SW, Mazer NA. Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system. J Urol. 1996;155(5):1604–8.  https://doi.org/10.1016/S0022-5347(01)66141-X.CrossRefPubMedGoogle Scholar
  35. 35.
    Carani C, Bancroft J, Granata A, Del Rio G, Marrama P. Testosterone and erectile function, nocturnal penile tumescence and rigidity, and erectile response to visual erotic stimuli in hypogonadal and eugonadal men. Psychoneuroendocrinology. 17(6):647–54.  https://doi.org/10.1016/0306-4530(92)90023-Z.
  36. 36.
    King BE, Packard MG, Alexander GM. Affective properties of intra-medial preoptic area injections of testosterone in male rats. Neurosci Lett. 1999;269(3):149–52.  https://doi.org/10.1016/S0304-3940(99)00440-1.CrossRefPubMedGoogle Scholar
  37. 37.
    Kwan M, Greenleaf WJ, Mann J, Crapo L, Davidson JM. The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men. J Clin Endocrinol Metab. 1983;57(3):557–62.  https://doi.org/10.1210/jcem-57-3-557.CrossRefPubMedGoogle Scholar
  38. 38.
    Redouté J, Stoléru S, Pugeat M, Costes N, Lavenne F, Le Bars D, et al. Brain processing of visual sexual stimuli in treated and untreated hypogonadal patients. Psychoneuroendocrinology. 30(5):461–82.  https://doi.org/10.1016/j.psyneuen.2004.12.003.
  39. 39.
    • Brock G, Heiselman D, Maggi M, Kim SW, Rodriguez Vallejo JM, Behre HM, et al. Effect of testosterone solution 2% on testosterone concentration, sex drive and energy in hypogonadal men: results of a placebo controlled study. J Urol. 2016;195(3):699–705.  https://doi.org/10.1016/j.juro.2015.10.083. This is the largest and most recent randomized placebo-controlled clinical trial investigating the effects of testosterone therapy on libido and energy level. CrossRefPubMedGoogle Scholar
  40. 40.
    • Paduch DA, Polzer PK, Ni X, Basaria S. Testosterone replacement in androgen-deficient men with ejaculatory dysfunction: a randomized controlled trial. J Clin Endocrinol Metab. 2015;100(8):2956–62.  https://doi.org/10.1210/jc.2014-4434. This is the only randomized placebo-controlled study evaluating the effect of testosterone therapy on ejaculatory function. CrossRefPubMedGoogle Scholar
  41. 41.
    •• Mulhall JP, Trost LW, Brannigan RE, Kurtz EG, Redmon JB, Chiles KA et al. Evaluation and management of testosterone deficiency: AUA Guideline. J Urol. 2018. doi: https://doi.org/10.1016/j.juro.2018.03.115. This includes the most recent American Urological Association guidelines supporting the treatment of testosterone deficiency.

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Sevann Helo
    • 1
  • Peyton Thomas
    • 2
  • Nicholas N. Tadros
    • 1
  1. 1.Division of UrologySouthern Illinois University School of MedicineSpringfieldUSA
  2. 2.Southern Illinois University School of MedicineCarbondaleUSA

Personalised recommendations